الفهرس 
DIABETES MELLITUS AND DIABETIC COMPLICATIONSOnly 14 pages are availabe for public view
 |  | from | 273 |  |  |
| | | from | 273 | | |
Abstract
Abstract
Diabetic neuropathy is associated with endothelial dysfunction and chronic inflammation and an adjuvant risk factor contributing to inflammation state, such as decreased levels of plasma IGF-1 level, may accelerate or aggravate the development or progression of diabetic neuropathy.
The aim of the study was to assess the relationship between insulin-like growth factor-1 (IGF-1) and painful diabetic neuropathy (DNP) in diabetic patients.
This was an observational study which was conducted on 90 diabetic patients at diabetes outpatient clinic at Ain Shams University Hospital, over period of 6 months from April 2023 to December 2023 to investigate plasma insulin-like growth factor-1 (IGF-1) as a screening and diagnostic indicator for assessing diabetic neuropathy risk in patients with diabetes mellitus.